313 related articles for article (PubMed ID: 35463299)
1. Current Prognostic and Predictive Biomarkers for Endometrial Cancer in Clinical Practice: Recommendations/Proposal from the Italian Study Group.
Zannoni GF; Bragantini E; Castiglione F; Fassan M; Troncone G; Inzani F; Pesci A; Santoro A; Fraggetta F
Front Oncol; 2022; 12():805613. PubMed ID: 35463299
[TBL] [Abstract][Full Text] [Related]
2. Biomarker characterization in endometrial cancer in Italy: first survey data analysis.
Zannoni GF; Santoro A; D'Alessandris N; Scaglione G; Inzani F; Angelico G; Bragantini E; Piermattei A; Cianfrini F; Bisaro B; Fassan M;
Pathologica; 2022 Jun; 114(3):189-198. PubMed ID: 35775705
[TBL] [Abstract][Full Text] [Related]
3. Incorporation of molecular characteristics into endometrial cancer management.
Vermij L; Smit V; Nout R; Bosse T
Histopathology; 2020 Jan; 76(1):52-63. PubMed ID: 31846532
[TBL] [Abstract][Full Text] [Related]
4. Integrated clinicopathologic and molecular analysis of endometrial carcinoma: Prognostic impact of the new ESGO-ESTRO-ESP endometrial cancer risk classification and proposal of histopathologic algorithm for its implementation in clinical practice.
de Biase D; Maloberti T; Corradini AG; Rosini F; Grillini M; Ruscelli M; Coluccelli S; Altimari A; Gruppioni E; Sanza V; Turchetti D; Galuppi A; Ferioli M; Giunchi S; Dondi G; Tesei M; Ravegnini G; Abbati F; Rubino D; Zamagni C; De Iaco P; Santini D; Ceccarelli C; Perrone AM; Tallini G; De Leo A
Front Med (Lausanne); 2023; 10():1146499. PubMed ID: 37064027
[TBL] [Abstract][Full Text] [Related]
5. New concepts for an old problem: the diagnosis of endometrial hyperplasia.
Sanderson PA; Critchley HO; Williams AR; Arends MJ; Saunders PT
Hum Reprod Update; 2017 Mar; 23(2):232-254. PubMed ID: 27920066
[TBL] [Abstract][Full Text] [Related]
6. Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice.
Fassan M; Scarpa A; Remo A; De Maglio G; Troncone G; Marchetti A; Doglioni C; Ingravallo G; Perrone G; Parente P; Luchini C; Mastracci L
Pathologica; 2020 Sep; 112(3):248-259. PubMed ID: 33179625
[TBL] [Abstract][Full Text] [Related]
7. The rise of a novel classification system for endometrial carcinoma; integration of molecular subclasses.
McAlpine J; Leon-Castillo A; Bosse T
J Pathol; 2018 Apr; 244(5):538-549. PubMed ID: 29344951
[TBL] [Abstract][Full Text] [Related]
8. Morphological Spectrum and Pathological Parameters of Type 2 Endometrial Carcinoma: A Comparison With Type 1 Endometrial Cancers.
Hashmi AA; Iftikhar SN; Ali J; Shaheen F; Afroze F; Imran A
Cureus; 2020 Oct; 12(10):e11025. PubMed ID: 33214953
[TBL] [Abstract][Full Text] [Related]
9. Can miRNAs be useful biomarkers in improving prognostic stratification in endometrial cancer patients? An update review.
Ravegnini G; Gorini F; De Crescenzo E; De Leo A; De Biase D; Di Stanislao M; Hrelia P; Angelini S; De Iaco P; Perrone AM
Int J Cancer; 2022 Apr; 150(7):1077-1090. PubMed ID: 34706070
[TBL] [Abstract][Full Text] [Related]
10. Molecular Classification of Endometrial Carcinoma: Protocol for a Cohort Study.
Moreira I; Bartosch C; Teixeira M; Ferreira M
JMIR Res Protoc; 2022 Aug; 11(8):e34461. PubMed ID: 35925678
[TBL] [Abstract][Full Text] [Related]
11. The brave new world of endometrial cancer : Future implications for adjuvant treatment decisions.
Marnitz S; Waltar T; Köhler C; Mustea A; Schömig-Markiefka B
Strahlenther Onkol; 2020 Nov; 196(11):963-972. PubMed ID: 32430662
[TBL] [Abstract][Full Text] [Related]
12. Confirmation of ProMisE: A simple, genomics-based clinical classifier for endometrial cancer.
Talhouk A; McConechy MK; Leung S; Yang W; Lum A; Senz J; Boyd N; Pike J; Anglesio M; Kwon JS; Karnezis AN; Huntsman DG; Gilks CB; McAlpine JN
Cancer; 2017 Mar; 123(5):802-813. PubMed ID: 28061006
[TBL] [Abstract][Full Text] [Related]
13. Molecular testing in endometrial carcinoma - joint recommendation of Czech Oncological Society, Oncogynecological Section of the Czech Gynecological and Obstetrical Society, Society of Radiation Oncology, Biology and Physics, and the Society of Czech Pathologists.
Dundr Pavel; Cibula David; Doležel Martin; Fabián Pavel; Fínek Jindřich; Jirásek Tomáš; Matěj Radoslav; Petruželka Luboš; Rob Lukáš; Ryška Aleš; Švajdler Marián; Weinberger Vít; Zikán Michal
Ceska Gynekol; 2021; 86(4):264-272. PubMed ID: 34493052
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Impact of Pathologic Features in Molecular Subgroups of Endometrial Carcinoma.
Ruscelli M; Maloberti T; Corradini AG; Rosini F; Querzoli G; Grillini M; Altimari A; Gruppioni E; Sanza V; Costantino A; Ciudino R; Errani M; Papapietro A; Coluccelli S; Turchetti D; Ferioli M; Giunchi S; Dondi G; Tesei M; Ravegnini G; Abbati F; Rubino D; Zamagni C; D'Angelo E; De Iaco P; Santini D; Ceccarelli C; Perrone AM; Tallini G; de Biase D; De Leo A
J Pers Med; 2023 Apr; 13(5):. PubMed ID: 37240893
[TBL] [Abstract][Full Text] [Related]
15. New Pathological and Clinical Insights in Endometrial Cancer in View of the Updated ESGO/ESTRO/ESP Guidelines.
Santoro A; Angelico G; Travaglino A; Inzani F; Arciuolo D; Valente M; D'Alessandris N; Scaglione G; Fiorentino V; Raffone A; Zannoni GF
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34073635
[TBL] [Abstract][Full Text] [Related]
16. Current and Emerging Prognostic Biomarkers in Endometrial Cancer.
Njoku K; Barr CE; Crosbie EJ
Front Oncol; 2022; 12():890908. PubMed ID: 35530346
[TBL] [Abstract][Full Text] [Related]
17. Recent Advances in the Classification of Gynecological Tract Tumors: Updates From the 5th Edition of the World Health Organization "Blue Book".
Parkash V; Aisagbonhi O; Riddle N; Siddon A; Panse G; Fadare O
Arch Pathol Lab Med; 2023 Oct; 147(10):1204-1216. PubMed ID: 36596270
[TBL] [Abstract][Full Text] [Related]
18. Update in the molecular classification of endometrial carcinoma.
Léon-Castillo A
Int J Gynecol Cancer; 2023 Mar; 33(3):333-342. PubMed ID: 36878561
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
Buza N
Semin Diagn Pathol; 2022 Jan; 39(1):58-77. PubMed ID: 34750021
[TBL] [Abstract][Full Text] [Related]
20. TCGA Molecular Prognostic Groups of Endometrial Carcinoma: Current Knowledge and Future Perspectives.
Arciuolo D; Travaglino A; Raffone A; Raimondo D; Santoro A; Russo D; Varricchio S; Casadio P; Inzani F; Seracchioli R; Mollo A; Mascolo M; Zannoni GF
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36232987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
